Inventor
LLOYD DAVID J
CA21 patents
⚠️ This page may combine multiple inventors who share the name “LLOYD DAVID J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALCAN INT LTD
12 patentsUS5616189AApr 1, 1997
Aluminum alloys and process for making aluminum alloy sheet
ALCAN INT LTD60 citations95
US5523050AJun 4, 1996
Method of preparing improved eutectic or hyper-eutectic alloys and composites based thereon
ALCAN INT LTD24 citations92
US5913989AJun 22, 1999
Process for producing aluminum alloy can body stock
ALCAN INT LTD22 citations86
US5306362AApr 26, 1994
Aluminum alloy and method of making
ALCAN INT LTD9 citations73
US4929421AMay 29, 1990
Aluminum alloys and a method of production
ALCAN INT LTD10 citations73
US6015528AJan 18, 2000
Apparatus and process for casting metal matrix composite materials
ALCAN INT LTD6 citations72
US5255433AOct 26, 1993
Engine block cylinder liners made of aluminum alloy composites
ALCAN INT LTD12 citations72
US5246057ASep 21, 1993
Cast composite materials having an al-mg matrix alloy
ALCAN INT LTD14 citations72
US5588478ADec 31, 1996
Control of sticking in twin roll casting
ALCAN INT LTD14 citations70
US5028392AJul 2, 1991
Melt process for the production of metal-matrix composite materials with enhanced particle/matrix wetting
ALCAN INT LTD11 citations68
US5299724AApr 5, 1994
Apparatus and process for casting metal matrix composite materials
ALCAN INT LTD4 citations61
US6257312B1Jul 10, 2001
Preparation of metal-matrix composite materials with high particulate loadings by concentration
ALCAN INT LTD4 citations60
AMGEN INC
5 patentsUS11046774B2Jun 29, 2021
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
AMGEN INC5 citations81
US10294303B2May 21, 2019
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
AMGEN INC12 citations81
US12252540B2Mar 18, 2025
Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)
AMGEN INC1 citations71
US12465652B2Nov 11, 2025
Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (GIPR)/GLP-1 receptor agonist fusion proteins
AMGEN INC0 citations60
US12435149B2Oct 7, 2025
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
AMGEN INC0 citations58